Clinical trial
Observation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease(CKD)Patients With Heart Failure
NCT03771729 is registered in ClinicalTrials.gov with The Second Affiliated Hospital of Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease(CKD)Patients With Heart Failure
- Lead sponsor
- The Second Affiliated Hospital of Harbin Medical University
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 30, 2018
- Completion date
- June 15, 2019
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ckd